Medicare Benefits Schedule - Note TN.8.40

Search Results for Note TN.8.40

View Related Items

Category 3 - THERAPEUTIC PROCEDURES

TN.8.40

Selective Internal Radiation Therapy (SIRT) using SIR-Spheres - (Items 35404, 35406 and 35408)

These items were introduced into the Schedule on an interim basis in May 2006 following a recommendation of the Medical Services Advisory Committee (MSAC) pending the outcome of clinical trials and further consideration by the MSAC. SIRT should not be performed in an outpatient or day patient setting to ensure patient and radiation safety requirements are met.

Related Items: 35404 35406 35408


Related Items

Category 3 - THERAPEUTIC PROCEDURES

35404

35404 - Additional Information

Item Start Date:
01-May-2006
Description Start Date:
01-May-2006
Schedule Fee Start Date:
01-Nov-2012

DOSIMETRY, HANDLING AND INJECTION OF SIR-SPHERES for selective internal radiation therapy of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

The procedure must be performed by a specialist or consultant physician recognised in the specialties of nuclear medicine or radiation oncology on an admitted patient in a hospital. To be claimed once in the patient's lifetime only.

Fee: $346.60 Benefit: 75% = $259.95

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)

Category 3 - THERAPEUTIC PROCEDURES

35406

35406 - Additional Information

Item Start Date:
01-May-2006
Description Start Date:
01-May-2006
Schedule Fee Start Date:
01-Nov-2012

Trans-femoral catheterisation of the hepatic artery to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

excluding associated radiological services or preparation, and excluding aftercare

(Anaes.) (Assist.)

Fee: $813.30 Benefit: 75% = $610.00

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)

Category 3 - THERAPEUTIC PROCEDURES

35408

35408 - Additional Information

Item Start Date:
01-May-2006
Description Start Date:
01-May-2006
Schedule Fee Start Date:
01-Nov-2012

Catheterisation of the hepatic artery via a permanently implanted hepatic artery port to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies

excluding associated radiological services or preparation, and excluding aftercare

(Anaes.) (Assist.)

Fee: $610.10 Benefit: 75% = $457.60

(See para TN.3.1, TN.8.40 of explanatory notes to this Category)


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change